EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

06.07.10

The Gates Foundation-Connected GlaxoSmithKline Indirectly Paid Scientists to Exaggerate Vaccine Needs

Posted in Bill Gates, Intellectual Monopoly, Patents at 5:15 am by Dr. Roy Schestowitz

GlaxoSmithKline logo

Summary: The philanthrocapitalist establishment whose Head of Global Health comes from GlaxoSmithKline has its work put to great scrutiny

THE Gates Foundation does not get much of a break because more and more people are beginning to understand its interests. It’s more complex than just “charity” as profit is being made without the foundation ever been taxed like a normal investor.

Today we turn our sceptical eye to the issue of patents and how the Gates Foundation promotes them. There is no question about the fact that Africa suffers from deadly diseases and Gates’ endeavours there are mostly commendable [1, 2]. It is a short-term solution which probably works well for both sides.

“The Gates Foundation acts as somewhat of a PR shim that intervenes where patents interfere/intersect with human toll.”What ought to be better understood is Bill Gates’ close relationship and interpersonal ties with the world’s largest pharmaceutical companies, which even work well inside the Gates Foundation (holding key positions). The Gates Foundation acts as somewhat of a PR shim that intervenes where patents interfere/intersect with human toll. It’s a marriage of convenience because the price of life is the route to big profits.

The following new report from The Guardian reveals that flu experts were indirectly being paid by pharmaceutical giants in order to overplay the risk of swine flu and thus increase sales of vaccines. GlaxoSmithKline (GSK) is mentioned among the culprits. [via Richard stallman]

Report condemns swine flu experts’ ties to big pharma

Scientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.

An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.

City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to the forefront of public health debate after dramatic predictions last year about a swine flu pandemic did not come true.

GSK was mentioned by us earlier today. We promised to revisit the subject because according to Portfolio.com, not only does the Gates Foundation have staff from GSK but it also has power over GSK:

The Bill & Melinda Gates Foundation was a driving force behind GlaxoSmithKline Plc’s decision to share propietary drug research for fighting malaria, the Puget Sound Business Journal reports.

That’s the same GSK which corrupted science in order to increase sales. That’s the same GSK which brought to the Gates Foundation its Head of Global Health, who bullies researchers. Gates Keepers writes about those patented drugs which the Gates Foundation is promoting:

Read this carefully: “so that all the people who are smart about the disease are to some degree on the same side, working together.” Here is a fatal flaw. Gates thinks that you can define “all the people who are smart about the disease” and invite them to work together. He and his staff wouldn’t know how to begin to find “all the people”. They are elite technocrats. How many people LIVING with the disease are working together on his elite panels?

This whole “parenthood” role which the Gates Foundation has been taking for years is sometimes just a tad insulting (patronising even) and it marginalises opposing/alternative points of view. Researchers often complain about that. Here is someone who is challenging their priorities:

Gates really, really likes the idea of using vertical funds to tackle (and eliminated) diseases one by one, rather than taking a more gradual, measured approach. Why do the big philanthropists (Gates, and by proxy, Buffet) prefer to take such a direct approach, circumventing governments?

The easiest explanation is through personality or experience: Gates is an entrepreneur, used to getting smart people in a room together to solve problems; private solutions for important problems. Governments have, if anything, been a source of irritation for him, lobbing the occasional anti-trust action at Microsoft.

[...]

I think it’s probably unrealistic to expect the Gates Foundation to start up a health SWAp anytime soon – the same factors that led to its creation will always drive it to tackle problems the way it does. What we should hope (and push) for is a commitment to “do no harm.” This means reverting to practices that do not distort health objectives on the ground (i.e. internal brain drain of qualified health staff, shifting the debate away from enforcing health systems to tackling single diseases). Working on vaccines, either through direct funding or advance market commitments, is a an example of high risk but less distortionary practice. The huge sums of money the Foundation juggles could also be used to create incentives for more general research into fighting tropical maladies, and then subsequently subsidise the price for needy countries.

Here is another new example from NYTimes.com. It’s very relevant to the above example.

“iBio and Fraunhofer USA Center for Molecular Biotechnology Enter Agreement to Provide Global Access for Bill & Melinda Gates Foundation Vaccines,” says the title of this new press release.

iBio, Inc. and the Fraunhofer USA Center for Molecular Biotechnology (CMB) announced today an agreement which provides a license of iBio’s proprietary technology to CMB for the development and manufacture of Global Health Vaccines for, and financed by, the Bill & Melinda Gates Foundation.

To avoid misunderstandings, the problem here is not vaccinations. Immunology and drugs are important and often vital for the saving of lives, but the economics here are a tricky operation that leaves the public out in the dark. The drugs industry is not just another industry like IT. The drug industry is massive and that’s where the big money is. Gates has investments in this industry, so it’s in his interest to promote it. Another related area is biotechnology, where Monsanto got itself a nice monopoly on the food chain. “Bill Gates reveals support for GMO eg,” says this headline from last year (one that we’ve just found and missed at the time, even though we already quite knowingly stated the facts [1, 2, 3, 4, 5, 6, 7, 8]).

As it has come to dominate the agenda for reshaping African agriculture over the years, the Bill and Melinda Gates Foundation has been very careful not to associate itself too closely with patent-protected biotechnology as a panacea for African farmers.

True, the foundation named 25-year Monsanto veteran Rob Horsch to the position of “senior program officer, focusing on improving crop yields in sub-Saharan Africa.”

Yet its flagship program for African ag, the Alliance for a Green Revolution in Africa (AGRA), explicitly distances itself from GMOs. “AGRA does not fund the development of GMOs,” the organization’s Web site states.

But AGRA — co-funded by the Rockefeller Foundation, proud sponsor of the original Green Revolution — is just part of what Gates does around African ag. What precisely is the foundation getting up to over there? Is it pushing GMOs on African smallholder farms?

Earlier on we wrote about GSK inside the Gates Foundation (Head of Global Health), but what many people overlook is that fact that there are Monsanto employees inside the Gates Foundation. They use the Gates Foundation as a seemingly ‘charitable’ lobby vehicle through which to advance the companies’ objectives, often at the expense of the public (which pays government tax to be funneled into patents on drugs for the developing world). It’s a simple matter of economics, creating scarcity with patents while profiting from massive tax-free investments.

There is another couple of new articles worth paying attention to:

Critics castigate Gastes Foundation on policy demands; India launches native H1N1 vaccines;

[...]

While the Gates Foundation has been widely lauded for its work on a wide range of initiatives, including financing research on new vaccines to guard against common killers in developing nations, some critics have emerged to caution against the foundation’s demands to “toe the line” on its position in policy debates.

Watch another man from the Gates Foundation offering “farming aid” (possibly a veiled reference to GMO):

Prior to joining the Obama Administration, Shah served as director of Agricultural Development in the Global Development Program at the Bill and Melinda Gates Foundation. In his seven years with the Gates Foundation, Shah served as the Foundation’s director of Strategic Opportunities and as deputy director of policy and finance for the Global Health Program.

They are getting increasingly connected to politics. Last week in The Times of India:

Obama appoints Indian-American to head U.S National Science Foundation

[...]

Clinton has Rajiv Shah, a former Gates Foundation executive and health expert, heading the USAID.

Clinton is connected to Bill Gates in ways that we explained before. When it comes to the Gates Foundation, former staff is often pursuing similar agendas after departure. To quote this new press release:

Academic Pharmacy Continues to Expand its Horizons at 2010 AACP Annual Meeting

[...]

He was the first business executive to serve as a public school superintendent and was the first executive director for the Bill & Melinda Gates Foundation.

This probably brings us to the subject of our next post, which says more about Gates Foundation influence on public schools [1, 2, 3, 4, 5].

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Links 22/2/2018: Qt Roadmap for 2018, Calculate Linux 17.12.2

    Links for the day



  2. As Expected, Bristows and Others Already Lying About UPC Status in Germany, But Doing This Anonymously (to Dodge Accountability for Lies)

    In their characteristic fashion, firms that created the UPC for their self-enrichment purposes, along with publishers/writers who deem it their role to promote the UPC and set up lobbying events for the UPC, look for ways to downplay if not intentionally distort what happened in Germany yesterday



  3. Further Attacks on EPO Staff and the Appeal Boards; Former EPO Boards of Appeal Member Speaks About EPO Scandals

    In the process of devaluing EPO workers and perhaps preparing them for a large round of layoffs information is also revealed about further repressions against the independence of the Boards of Appeal



  4. End of the UPC Lobby and Withdrawal of UPCA May Seem Imminent

    The Unitary Patent fantasy (of mass litigation firms) is coming to an end; in fact, the German government and courts (Bundesverfassungsgericht to be specific) now deem the complaint to be admissible and thus likely legitimate in spite of many attempts to shoot it down



  5. EPO's Board 28 Spikes Article 53 in CA/3/18, Apparently After Battistelli Withdrew It

    The latest plot twist, as odd as that may seem, is that the attack on the rights of thousands of workers (many of whom are rumoured to be on their way out) is curtailed somewhat, at least for the time being



  6. Links 21/2/2018: Apper 1.0, New Fedora ISOs

    Links for the day



  7. Rumour: European Patent Office to Lay Off a Significant Proportion of Its Workforce

    While the Administrative Council of the EPO praises Battistelli for his financial accomplishments (as laughable as it may seem) a lot of families stuck in a foreign country may soon see their breadwinner unemployed, according to rumours



  8. The Patent Trolls' Lobby, Bristows and IAM Among Others, Downplays Darts-IP/IP2Innovate Report About Rising If Not Soaring Troll Activity in Europe

    Exactly like last year, as soon as IP2Innovate opens its mouth Bristows and IAM go into "attack dog" mode and promote the UPC, deny the existence or seriousness of patent trolls, and promote their nefarious, trolls-funded agenda



  9. Links 20/2/2018: Mesa 17.3.5, Qt 5.11 Alpha, Absolute 15.0 Beta 4, Sailfish OS 2.1.4 E.A., SuiteCRM 7.10

    Links for the day



  10. Replacing Patent Sharks/Trolls and the Patent Mafia With 'Icons' Like Thomas Edison

    The popular perceptions of patents and the sobering reality of what patents (more so nowadays) mean to actual inventors who aren't associated with global behemoths such as IBM or Siemens



  11. The Patent Trolls' Lobby is Distorting the Record of CAFC on PTAB

    The Court of Appeals for the Federal Circuit (CAFC), which deals with appeals from PTAB, has been issuing many decisions in favour of § 101, but those aren't being talked about or emphasised by the patent 'industry'



  12. Japan Demonstrates Sanity on SEP Policy While US Patent Policy is Influenced by Lobbyists

    Japan's commendable response to a classic pattern of patent misuse; US patent policy is still being subjected to never-ending intervention and there is now a lobbyist in charge of antitrust matters and a lawyer in charge of the US patent office (both Trump appointees)



  13. The Patent Microcosm's Embrace of Buzzwords and False Marketing Strives to Make Patent Examiners Redundant and Patent Quality Extremely Low

    Patent maximalists, who are profiting from abundance of low-quality patents (and frivolous lawsuits/legal threats these can entail), are riding the hype wave and participating in the rush to put patent systems at the hands of machines



  14. Today, at 12:30 CET, Bavarian State Parliament Will Speak About EPO Abuses (Updated)

    The politicians of Bavaria are prepared to wrestle with some serious questions about the illegality of the EPO's actions and what that may mean to constitutional aspects of German law



  15. Another Loud Warning From EPO Workers About the Decline of Patent Quality

    Yet more patent quality warnings are being issued by EPO insiders (examiners) who are seeing their senior colleagues vanishing and wonder what will be left of their employer



  16. Links 19/2/2018: Linux 4.16 RC2, Nintendo Switch Now Full-fledged GNU/Linux

    Links for the day



  17. PTAB Continues to Invalidate a Lot of Software Patents and to Stop Patent Examiners From Issuing Them

    Erasure of software patents by the Patent Trial and Appeal Board (PTAB) carries on unabated in spite of attempts to cause controversy and disdain towards PTAB



  18. The Patent 'Industry' Likes to Mention Berkheimer and Aatrix to Give the Mere Impression of Section 101/Alice Weakness

    Contrary to what patent maximalists keep saying about Berkheimer and Aatrix (two decisions of the Federal Circuit from earlier this month, both dealing with Alice-type challenges), neither actually changed anything in any substantial way



  19. Makan Delrahim is Wrong; Patents Are a Major Antitrust Problem, Sometimes Disguised Using Trolls Somewhere Like the Eastern District of Texas

    Debates and open disagreements over the stance of the lobbyist who is the current United States Assistant Attorney General for the Antitrust Division



  20. Patent Trolls Watch: Microsoft-Connected Intellectual Ventures, Finjan, and Rumour of Technicolor-InterDigital Buyout

    Connections between various patent trolls and some patent troll statistics which have been circulated lately



  21. Software Patents Trickle in After § 101/Alice, But Courts Would Not Honour Them Anyway

    The dawn of § 101/Alice, which in principle eliminates almost every software patent, means that applicants find themselves having to utilise loopholes to fool examiners, but that's unlikely to impress judges (if they ever come to assessing these patents)



  22. In Aatrix v Green Shades the Court is Not Tolerating Software Patents But Merely Inquires/Wonders Whether the Patents at Hand Are Abstract

    Aatrix alleges patent infringement by Green Shades, but whether the patents at hand are abstract or not remains to be seen; this is not what patent maximalists claim it to be ("A Valentine for Software Patent Owners" or "valentine for patentee")



  23. An Indoctrinated Minority is Maintaining the Illusion That Patent Policy is to Blame for All or Most Problems of the United States

    The zealots who want to patent everything under the Sun and sue everyone under the Sun blame nations in the east (where the Sun rises) for all their misfortunes; this has reached somewhat ludicrous levels



  24. Berkheimer Decision is Still Being Spun by the Anti-Section 101/Alice Lobby

    12 days after Berkheimer v HP Inc. the patent maximalists continue to paint this decision as a game changer with regards to patent scope; the reality, however, is that this decision will soon be forgotten about and will have no substantial effect on either PTAB or Alice (because it's about neither of these)



  25. Academic Patent Immunity is Laughable and Academics Are Influenced by Corporate Money (for Steering Patent Agenda)

    Universities appear to have become battlegrounds in the war between practicing entities and a bunch of parasites who make a living out of litigation and patent bubbles



  26. UPC Optimism Languishes Even Among Paid UPC Propagandists Such as IAM

    Even voices which are attempting to give UPC momentum that it clearly lacks admit that things aren't looking well; the UK is not ratifying and Germany make take years to look into constitutional barriers



  27. Bejin Bieneman Props Up the Disgraced Randall Rader for Litigation Agenda

    Randall Rader keeps hanging out with the litigation 'industry' -- the very same 'industry' which he served in a closeted fashion when he was Chief Judge of the Federal Circuit (and vocal proponent of software patents, patent trolls and so on)



  28. With Stambler v Mastercard, Patent Maximalists Are Hoping to Prop Up Software Patents and Damage PTAB

    The patent 'industry' is hoping to persuade the highest US court to weaken the Patent Trial and Appeal Board (PTAB), for PTAB is making patent lawsuits a lot harder and raises the threshold for patent eligibility



  29. Apple Discovers That Its Patent Disputes Are a Losing Battle Which Only Lawyers Win (Profit From)

    By pouring a lot of money and energy into the 'litigation card' Apple lost focus and it's also losing some key cases, as its patents are simply not strong enough



  30. The Patent Microcosm Takes Berkheimer v HP Out of Context to Pretend PTAB Disregards Fact-Finding Process

    In view or in light of a recent decision (excerpt above), patent maximalists who are afraid of the Patent Trial and Appeal Board (PTAB) try to paint it as inherently unjust and uncaring for facts


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts